2.25
Schlusskurs vom Vortag:
$2.26
Offen:
$2.24
24-Stunden-Volumen:
50,498
Relative Volume:
0.18
Marktkapitalisierung:
$20.20M
Einnahmen:
$93.76M
Nettoeinkommen (Verlust:
$-13.68M
KGV:
-0.8555
EPS:
-2.63
Netto-Cashflow:
$8.77M
1W Leistung:
-4.26%
1M Leistung:
-9.27%
6M Leistung:
+78.57%
1J Leistung:
-6.25%
Aytu Biopharma Inc Stock (AYTU) Company Profile
Firmenname
Aytu Biopharma Inc
Sektor
Telefon
(720) 437-6580
Adresse
7900 E. UNION AVENUE, DENVER
Vergleichen Sie AYTU mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
AYTU
Aytu Biopharma Inc
|
2.25 | 20.29M | 93.76M | -13.68M | 8.77M | -2.63 |
![]()
ZTS
Zoetis Inc
|
153.32 | 67.90B | 9.39B | 2.62B | 2.22B | 5.81 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
15.40 | 48.29B | 29.96B | 957.25M | 4.77B | 0.304 |
![]()
HLN
Haleon Plc Adr
|
9.80 | 44.04B | 14.26B | 1.98B | 2.47B | 0.4347 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.95 | 21.20B | 16.70B | -157.13M | 1.19B | -0.155 |
![]()
UTHR
United Therapeutics Corp
|
400.52 | 17.21B | 2.99B | 1.21B | 1.13B | 25.06 |
Aytu Biopharma Inc Stock (AYTU) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-07-01 | Eingeleitet | Lake Street | Buy |
2025-06-30 | Eingeleitet | Ascendiant Capital Markets | Buy |
2021-03-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
2020-05-29 | Eingeleitet | H.C. Wainwright | Buy |
Aytu Biopharma Inc Aktie (AYTU) Neueste Nachrichten
Key metrics from Aytu BioPharma Inc.’s quarterly dataWatch List & Real-Time Market Sentiment Reports - Newser
Custom watchlist performance reports with Aytu BioPharma Inc.2025 Momentum Check & Low Risk High Win Rate Picks - Newser
What data driven models say about Aytu BioPharma Inc.’s futureWeekly Volume Report & High Conviction Buy Zone Picks - Newser
Will Aytu BioPharma Inc. rebound enough to break evenJuly 2025 Fed Impact & Long-Term Safe Investment Ideas - Newser
How to recover losses in Aytu BioPharma Inc. stockM&A Rumor & Community Trade Idea Sharing Platform - Newser
Is Aytu BioPharma Inc. showing signs of accumulationWatch List & Consistent Growth Equity Picks - Newser
Should you avoid Aytu BioPharma Inc. stock right nowTrade Exit Report & AI Optimized Trade Strategies - خودرو بانک
Is Aytu BioPharma Inc. stock a top performer YTDJuly 2025 Drop Watch & Consistent Profit Focused Trading Strategies - خودرو بانک
Does Aytu BioPharma Inc. align with a passive investing strategyEarnings Miss & AI Powered Buy and Sell Recommendations - خودرو بانک
Is Aytu BioPharma Inc. a defensive stockJuly 2025 Levels & Free Weekly Watchlist of Top Performers - خودرو بانک
Will Aytu BioPharma Inc. see short term momentumWeekly Trade Review & High Win Rate Trade Alerts - Newser
Can Aytu BioPharma Inc. benefit from deglobalizationJuly 2025 Market Mood & Real-Time Market Trend Scan - خودرو بانک
Analyzing Aytu BioPharma Inc. with risk reward ratio chartsMarket Risk Analysis & Weekly High Potential Alerts - Newser
Will Aytu BioPharma Inc. continue its uptrendPortfolio Return Summary & Real-Time Buy Signal Alerts - Newser
Is Aytu BioPharma Inc. stock entering bullish territoryJuly 2025 Opening Moves & Capital Protection Trade Alerts - Newser
Is Aytu BioPharma Inc. forming a bottoming baseEarnings Beat & Growth Focused Stock Reports - Newser
Combining price and volume data for Aytu BioPharma Inc.2025 Earnings Impact & Safe Capital Allocation Plans - Newser
Certain Stock Options of Aytu BioPharma, Inc. are subject to a Lock-Up Agreement Ending on 4-SEP-2025. - MarketScreener
Live market analysis of Aytu BioPharma Inc.July 2025 Recap & Growth Focused Stock Reports - Newser
Risk vs reward if holding onto Aytu BioPharma Inc.Earnings Performance Report & AI Driven Stock Movement Reports - Newser
Fed Meeting: What hedge funds are buying Aytu BioPharma Inc.2025 Valuation Update & Scalable Portfolio Growth Ideas - خودرو بانک
What machine learning models say about Aytu BioPharma Inc.July 2025 Final Week & High Accuracy Trade Signal Alerts - Newser
Will Aytu BioPharma Inc. benefit from macro trendsWeekly Profit Analysis & Weekly Chart Analysis and Trade Guides - Newser
What hedge funds are buying Aytu BioPharma Inc.Weekly Risk Report & Daily Chart Pattern Signal Reports - خودرو بانک
Why Aytu BioPharma Inc. is moving todayShare Buyback & Free Daily Entry Point Trade Alerts - Newser
How to manage a losing position in Aytu BioPharma Inc.July 2025 Decliners & Low Drawdown Investment Strategies - Newser
Is Aytu BioPharma Inc. trending in predictive chart modelsMarket Sentiment Report & Daily Profit Focused Screening - Newser
What is Aytu BioPharma Inc.’s valuation compared to sector2025 Technical Patterns & Smart Money Movement Tracker - خودرو بانک
VIX Spike: Is Aytu BioPharma Inc. still a buy after recent gains2025 Momentum Check & Safe Entry Trade Reports - خودرو بانک
Is Aytu BioPharma Inc. still a buy after recent gainsQuarterly Market Review & Growth Focused Stock Reports - خودرو بانک
Detecting price anomalies in Aytu BioPharma Inc. with AIVolume Spike & Weekly Chart Analysis and Trade Guides - Newser
Fibonacci Levels Suggest Recovery for Aytu BioPharma Inc. getLinesFromResByArray error: size == 0 - 더경남뉴스
Finanzdaten der Aytu Biopharma Inc-Aktie (AYTU)
Umsatz
Nettogewinn
Free Cashflow
ENV
Aytu Biopharma Inc-Aktie (AYTU) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
Disbrow Joshua R. | Chief Executive Officer |
Jun 09 '25 |
Buy |
1.50 |
66,666 |
99,999 |
153,257 |
Disbrow Joshua R. | Chief Executive Officer |
Feb 28 '25 |
Buy |
1.30 |
15,000 |
19,500 |
86,591 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):